Minnesota Medical Marijuana Conditions 

Medical marijuana is prescribed to many patients with different conditions. The Minnesota Department of Health is taking into consideration adding people with autism to the nonstop list of conditions which the patients can be given medical cannabis.

The consideration of medical marijuana carries a lot of feelings for families that have loved ones with this condition where not much is known about it.

In a life full of doubt and uncertainty, Kammy Krammer is confident about one thing; being prescribed medical cannabis helps her autistic son, Elliot in a great way. But 15-year-olds Elliot's autism is not the cause of why he can take medical cannabis under the Minnesota medical marijuana state law.


Kids with autism could soon be offered medical cannabis.

Kammy Krammer's son, Elliot suffered from bad anxiety. Elliot had tics every day that stopped him from having a normal relationship with his peers. He could not control his tics, so he felt embarrassed.

Kammy said her son Elliot began using medical marijuana July 1st, 2015 which is the first day it became legal in Minnesota- to help deal with his Tourette syndrome. Immediately he saw a reduction with his tics, but his mom also recognized that it was beneficial for a lot of the side effects that is associated with autism.

Tourettes, not autism is one of the few numbers of conditions where medical marijuana can be given to patients.

Now, the DOH is taking into account adding autism to the list, but they only have personal stories from parents like Kammy and children like Elliot that really works, causing a degree of uncertainty around a mysterious condition that has no cure.

Autism is the result of changes in how the brain receives information which then changes how the mind looks at the world. For someone suffering from autism, that most likely means communication issues, repetitive behaviors, and challenges with socializing with others.

As for how they are leaning on the decision, the DOH wrote a statement saying the process needs to run its course before we say anything about specific proposals. Minnesota's medical cannabis review team will report on the citizen's health benefits and risks of any prospective medical conditions by Nov. 1.